TechDogs - Sam Altman’s $2B+ Investments In OpenAI-Linked Companies Face Scrutiny Amid Musk Lawsuit"

Regulatory Technology (RegTech)

Sam Altman’s $2B+ Investments In OpenAI-Linked Companies Face Scrutiny Amid Musk Lawsuit

By Manali Kekade

Updated on Thu, May 14, 2026

Overall Rating
Questions around conflicts of interest in the AI industry are gaining attention again as new court filings bring OpenAI CEO Sam Altman’s investments under the spotlight. The disclosures come as part of an ongoing legal battle involving Elon Musk and broader regulatory reviews in the United States.

 

TL;DR

 
  • Court filings show Sam Altman has over $2B in stakes in companies linked to OpenAI during Elon Musk’s lawsuit.
  • U.S. regulators are checking OpenAI’s rules on conflicts of interest and governance ahead of a possible IPO.
  • Altman says he did nothing wrong and stepped back from related decisions.

Court documents presented during a hearing in Elon Musk’s lawsuit against OpenAI reveal that Sam Altman holds more than $2 billion in stakes in companies that have done business with OpenAI. Musk is seeking $150 billion in damages and has also called for Altman’s removal as CEO and board member, alleging breach of charitable trust and unjust enrichment. Altman has denied the allegations.

The filing also comes as 10 U.S. state attorneys general have asked the Securities and Exchange Commission to review OpenAI-related documents ahead of a possible initial public offering. In addition, the U.S. House Committee on Oversight and Government Reform has requested details on OpenAI’s policies to prevent conflicts of interest.

According to the court document, Altman’s holdings span nine companies that have business ties with OpenAI. These include a $1.7 billion stake in fusion energy company Helion Energy, a $633 million stake in financial software firm Stripe, and a $258 million stake in biotech company Retro Biosciences.

The document also shows Altman sold his stake in Reddit by the end of 2025. He previously held more than $600 million in the company when it went public in 2024.
 
Other companies listed in the filing include chip maker Cerebras, people management software firm Lattice, AI device maker Humane, and AI pharmaceutical company Trialspark, now known as Formation Bio.

Altman testified that he first invested in Helion in 2015 and has known its founders for years. He also said he was “stepped back” from decisions involving related deals and did not directly sign agreements where conflicts could exist. Altman has rejected claims of wrongdoing and said standard recusal practices were followed in situations involving companies he has invested in.

First published on Thu, May 14, 2026

Enjoyed what you've read so far? Great news - there's more to explore!

Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.

Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.

Dive into TechDogs' treasure trove today and Know Your World of technology!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.

Loading comments...

  • Dark
  • Light